Company / Depreciation & Amortization
Orthofix Medical Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$53.1M
FY2025
5-year range
$24.7M / $53.1M
FY2021-FY2025
Trend
+82.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization returned to growth in FY2025 after 2 years of decline, reaching $53M.
Based on SEC 10-K filings.
$53M in FY2025 with a 5-year CAGR of +23.2%.
Increased from $30M to $53M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +20.2%
- 5-Year CAGR
- +23.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +23.2%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 82.9% year-over-year.
- Lowest depreciation & amortization in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $53.1M | +82.9% |
| FY2024 | $29.0M | -2.0% |
| FY2023 | $29.6M | -3.1% |
| FY2022 | $30.5M | +23.7% |
| FY2021 | $24.7M | +32.4% |
| FY2020 | $18.7M | -7.3% |
| FY2019 | $20.1M | -3.4% |
| FY2018 | $20.8M | -0.4% |
| FY2017 | $20.9M | -8.5% |
| FY2016 | $22.9M | +0.2% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026